A major advance in cancer study is occurring with the use of mini-antibodies to reactivate mutated p53. This essential malignant inhibitor protein is frequently inactivated in various types of malignancies, causing https://pr6bookmark.com/story22159041/mini-antibodies-revive-tumor-suppressor-p53-the-potential-hope-for-cancer-treatment